You are here

Process Research and Scale-up of a Commercialisable Route to Maraviroc (UK-427,857), a CCR-5 Receptor Antagonist

Location: 
Online
Reading Order: 
1
Citation: 

Process Research and Scale-up of a Commercialisable Route to Maraviroc (UK-427,857), a CCR-5 Receptor Antagonist.
Jens Åhman, Melissa Birch, Sarah J. Haycock-Lewandowski, James, Long, and Alexander Wilder
Organic Process Research & Development 2008 12 (6), 1104-1113